Riskpilot← Back to searchSign inGet full accessBIOPRO CONSULT AS
ASActiveOrg 912592359Nordsetvegen 151, 7540 KlæbuSewerage · NACE 3700Est. 20130 employees
Revenue 2024
NOK 166K
+14% vs 2023
EBITDA margin
57.0%
-1% vs 2023
Equity ratio
80.1%
Financial strength
Net profit 2024
NOK 57K
-7% vs 2023
| Revenue | NOK 166K | +14% |
| EBITDA | NOK 95K | -1% |
| Net profit | NOK 57K | -7% |
| Total assets | NOK 365K | -10% |
| Equity | NOK 293K | +24% |
| Employees | 0 | — |
Legal name
BIOPRO CONSULT AS
Org number
912592359
Legal form
Aksjeselskap
NACE code
3700 · Sewerage
Founded
16. oktober 2013
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av biologisk avløpsanlegg og annet som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Nordsetvegen 151, 7540 Klæbu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 98 | 204 | 118 | 145 | 166 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 43 | 22 | 76 | 96 | 95 |
| Depreciation & amort. | −23 | −0 | −23 | −21 | −21 |
| EBIT | 20 | 22 | 53 | 75 | 73 |
| Net financials | −0 | 0 | 0 | 0 | −0 |
| Profit before tax | 20 | 22 | 53 | 75 | 73 |
| Tax | −0 | −0 | 12 | 14 | 16 |
| Net profit | 20 | 22 | 41 | 61 | 57 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 479 | 450 | 408 | 407 | 365 |
| Equity | 111 | 134 | 175 | 236 | 293 |
| Long-term debt | 9 | 9 | 2 | 0 | 0 |
| Short-term debt | 358 | 307 | 230 | 171 | 73 |
| Total debt | 368 | 316 | 233 | 171 | 73 |
EBITDA margin
57.0%
This company
15.8%
Market median
+261% vs market
20202024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
19.4%
This company
18.4%
Market median
+5% vs market
20202024
Net profit margin
34.2%
This company
8.1%
Market median
+322% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOPRO CONSULT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lillian Dahl Krokum | Chairman | 0 companies |